nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—CYP1A1—Dacarbazine—muscle cancer	0.092	0.148	CbGbCtD
Caffeine—CYP2E1—Dacarbazine—muscle cancer	0.071	0.114	CbGbCtD
Caffeine—CYP1B1—Doxorubicin—muscle cancer	0.0699	0.112	CbGbCtD
Caffeine—CYP1A2—Dacarbazine—muscle cancer	0.0411	0.0661	CbGbCtD
Caffeine—CYP3A7—Vincristine—muscle cancer	0.0393	0.0632	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0393	0.0632	CbGbCtD
Caffeine—CYP2E1—Etoposide—muscle cancer	0.0348	0.0559	CbGbCtD
Caffeine—ABCB1—Dactinomycin—muscle cancer	0.0311	0.0501	CbGbCtD
Caffeine—CYP3A5—Vincristine—muscle cancer	0.0295	0.0474	CbGbCtD
Caffeine—CYP3A5—Etoposide—muscle cancer	0.027	0.0434	CbGbCtD
Caffeine—CYP2C8—Etoposide—muscle cancer	0.026	0.0418	CbGbCtD
Caffeine—CYP1A2—Etoposide—muscle cancer	0.0201	0.0323	CbGbCtD
Caffeine—ABCB1—Vincristine—muscle cancer	0.0192	0.0308	CbGbCtD
Caffeine—ABCB1—Etoposide—muscle cancer	0.0176	0.0283	CbGbCtD
Caffeine—RYR1—larynx—muscle cancer	0.0145	0.102	CbGeAlD
Caffeine—ABCB1—Doxorubicin—muscle cancer	0.012	0.0193	CbGbCtD
Caffeine—ABCB1—Methotrexate—muscle cancer	0.0116	0.0187	CbGbCtD
Caffeine—CYP3A4—Vincristine—muscle cancer	0.0115	0.0185	CbGbCtD
Caffeine—CYP2D6—Doxorubicin—muscle cancer	0.0113	0.0182	CbGbCtD
Caffeine—CYP3A4—Etoposide—muscle cancer	0.0105	0.0169	CbGbCtD
Caffeine—CYP3A4—Doxorubicin—muscle cancer	0.00718	0.0115	CbGbCtD
Caffeine—PRKDC—Vinblastine—Vincristine—muscle cancer	0.00505	1	CbGdCrCtD
Caffeine—ATM—embryo—muscle cancer	0.00418	0.0296	CbGeAlD
Caffeine—PIK3CD—embryo—muscle cancer	0.0037	0.0263	CbGeAlD
Caffeine—PIK3CB—embryo—muscle cancer	0.00323	0.0229	CbGeAlD
Caffeine—PIK3CA—embryo—muscle cancer	0.0032	0.0227	CbGeAlD
Caffeine—ATM—renal system—muscle cancer	0.00316	0.0224	CbGeAlD
Caffeine—PRKDC—smooth muscle tissue—muscle cancer	0.0031	0.022	CbGeAlD
Caffeine—PIK3CD—smooth muscle tissue—muscle cancer	0.00291	0.0206	CbGeAlD
Caffeine—ATM—cardiac atrium—muscle cancer	0.00283	0.0201	CbGeAlD
Caffeine—PIK3CD—renal system—muscle cancer	0.0028	0.0199	CbGeAlD
Caffeine—PRKDC—cardiac atrium—muscle cancer	0.00268	0.019	CbGeAlD
Caffeine—PIK3CB—smooth muscle tissue—muscle cancer	0.00254	0.018	CbGeAlD
Caffeine—RYR1—smooth muscle tissue—muscle cancer	0.00251	0.0178	CbGeAlD
Caffeine—PIK3CA—smooth muscle tissue—muscle cancer	0.00251	0.0178	CbGeAlD
Caffeine—PIK3CB—renal system—muscle cancer	0.00244	0.0173	CbGeAlD
Caffeine—PIK3CA—renal system—muscle cancer	0.00242	0.0172	CbGeAlD
Caffeine—ATM—bone marrow—muscle cancer	0.00239	0.0169	CbGeAlD
Caffeine—PRKDC—tendon—muscle cancer	0.00233	0.0165	CbGeAlD
Caffeine—ATM—vagina—muscle cancer	0.00229	0.0162	CbGeAlD
Caffeine—PRKDC—bone marrow—muscle cancer	0.00226	0.016	CbGeAlD
Caffeine—PIK3CB—cardiac atrium—muscle cancer	0.00219	0.0155	CbGeAlD
Caffeine—PIK3CA—cardiac atrium—muscle cancer	0.00217	0.0154	CbGeAlD
Caffeine—PRKDC—vagina—muscle cancer	0.00216	0.0153	CbGeAlD
Caffeine—PIK3CD—bone marrow—muscle cancer	0.00212	0.015	CbGeAlD
Caffeine—ATM—head—muscle cancer	0.00211	0.015	CbGeAlD
Caffeine—ATM—testis—muscle cancer	0.00204	0.0145	CbGeAlD
Caffeine—PRKDC—testis—muscle cancer	0.00193	0.0137	CbGeAlD
Caffeine—PIK3CB—tendon—muscle cancer	0.00191	0.0135	CbGeAlD
Caffeine—RYR1—tendon—muscle cancer	0.00189	0.0134	CbGeAlD
Caffeine—PIK3CA—tendon—muscle cancer	0.00189	0.0134	CbGeAlD
Caffeine—PIK3CD—head—muscle cancer	0.00188	0.0133	CbGeAlD
Caffeine—ADORA2B—smooth muscle tissue—muscle cancer	0.00185	0.0131	CbGeAlD
Caffeine—PIK3CB—bone marrow—muscle cancer	0.00185	0.0131	CbGeAlD
Caffeine—PIK3CA—bone marrow—muscle cancer	0.00183	0.013	CbGeAlD
Caffeine—PIK3CD—testis—muscle cancer	0.00181	0.0128	CbGeAlD
Caffeine—PIK3CB—vagina—muscle cancer	0.00177	0.0126	CbGeAlD
Caffeine—RYR1—vagina—muscle cancer	0.00175	0.0124	CbGeAlD
Caffeine—PIK3CA—vagina—muscle cancer	0.00175	0.0124	CbGeAlD
Caffeine—PIK3CB—head—muscle cancer	0.00164	0.0116	CbGeAlD
Caffeine—PIK3CA—head—muscle cancer	0.00162	0.0115	CbGeAlD
Caffeine—RYR1—head—muscle cancer	0.00162	0.0115	CbGeAlD
Caffeine—PIK3CB—testis—muscle cancer	0.00158	0.0112	CbGeAlD
Caffeine—PIK3CA—testis—muscle cancer	0.00156	0.0111	CbGeAlD
Caffeine—RYR1—testis—muscle cancer	0.00156	0.0111	CbGeAlD
Caffeine—ADORA2B—vagina—muscle cancer	0.00129	0.00914	CbGeAlD
Caffeine—ADORA1—renal system—muscle cancer	0.00128	0.00907	CbGeAlD
Caffeine—ADORA2B—head—muscle cancer	0.00119	0.00844	CbGeAlD
Caffeine—ADORA2B—testis—muscle cancer	0.00115	0.00816	CbGeAlD
Caffeine—ADORA1—cardiac atrium—muscle cancer	0.00115	0.00812	CbGeAlD
Caffeine—ADORA1—tendon—muscle cancer	0.000998	0.00708	CbGeAlD
Caffeine—ADORA2A—head—muscle cancer	0.000991	0.00703	CbGeAlD
Caffeine—ADORA2A—testis—muscle cancer	0.000957	0.00679	CbGeAlD
Caffeine—ADORA1—vagina—muscle cancer	0.000926	0.00657	CbGeAlD
Caffeine—ADORA1—head—muscle cancer	0.000856	0.00607	CbGeAlD
Caffeine—PDE4B—cardiac atrium—muscle cancer	0.000847	0.00601	CbGeAlD
Caffeine—CYP1B1—smooth muscle tissue—muscle cancer	0.000842	0.00597	CbGeAlD
Caffeine—ADORA1—testis—muscle cancer	0.000827	0.00586	CbGeAlD
Caffeine—CYP1B1—renal system—muscle cancer	0.000811	0.00575	CbGeAlD
Caffeine—PDE4B—tendon—muscle cancer	0.000738	0.00523	CbGeAlD
Caffeine—PDE4B—bone marrow—muscle cancer	0.000715	0.00507	CbGeAlD
Caffeine—PDE4B—vagina—muscle cancer	0.000685	0.00486	CbGeAlD
Caffeine—PDE4B—head—muscle cancer	0.000633	0.00449	CbGeAlD
Caffeine—CYP1B1—tendon—muscle cancer	0.000633	0.00449	CbGeAlD
Caffeine—CYP2C8—renal system—muscle cancer	0.000621	0.0044	CbGeAlD
Caffeine—PDE4B—testis—muscle cancer	0.000611	0.00433	CbGeAlD
Caffeine—CYP1A2—renal system—muscle cancer	0.000581	0.00412	CbGeAlD
Caffeine—CYP1A1—renal system—muscle cancer	0.000573	0.00406	CbGeAlD
Caffeine—CYP3A5—renal system—muscle cancer	0.00056	0.00397	CbGeAlD
Caffeine—CYP1B1—head—muscle cancer	0.000543	0.00385	CbGeAlD
Caffeine—CYP1B1—testis—muscle cancer	0.000524	0.00371	CbGeAlD
Caffeine—CYP2E1—renal system—muscle cancer	0.000523	0.00371	CbGeAlD
Caffeine—Necrotising colitis—Doxorubicin—muscle cancer	0.000516	0.118	CcSEcCtD
Caffeine—CYP1A1—cardiac atrium—muscle cancer	0.000513	0.00364	CbGeAlD
Caffeine—CYP2C8—vagina—muscle cancer	0.00045	0.00319	CbGeAlD
Caffeine—CYP3A4—renal system—muscle cancer	0.000421	0.00298	CbGeAlD
Caffeine—CYP1A1—vagina—muscle cancer	0.000415	0.00294	CbGeAlD
Caffeine—CYP2D6—renal system—muscle cancer	0.000414	0.00293	CbGeAlD
Caffeine—CYP2E1—tendon—muscle cancer	0.000408	0.00289	CbGeAlD
Caffeine—CYP3A5—vagina—muscle cancer	0.000406	0.00288	CbGeAlD
Caffeine—CYP2C8—testis—muscle cancer	0.000401	0.00284	CbGeAlD
Caffeine—ABCB1—embryo—muscle cancer	0.000393	0.00279	CbGeAlD
Caffeine—CYP1A1—head—muscle cancer	0.000384	0.00272	CbGeAlD
Caffeine—CYP2E1—head—muscle cancer	0.00035	0.00248	CbGeAlD
Caffeine—CYP2E1—testis—muscle cancer	0.000338	0.00239	CbGeAlD
Caffeine—ABCB1—renal system—muscle cancer	0.000298	0.00211	CbGeAlD
Caffeine—CYP2D6—head—muscle cancer	0.000277	0.00196	CbGeAlD
Caffeine—CYP2D6—testis—muscle cancer	0.000268	0.0019	CbGeAlD
Caffeine—Cerebral haemorrhage—Vincristine—muscle cancer	0.000256	0.0586	CcSEcCtD
Caffeine—ABCB1—bone marrow—muscle cancer	0.000225	0.0016	CbGeAlD
Caffeine—ABCB1—vagina—muscle cancer	0.000216	0.00153	CbGeAlD
Caffeine—ABCB1—head—muscle cancer	0.000199	0.00141	CbGeAlD
Caffeine—ABCB1—testis—muscle cancer	0.000192	0.00136	CbGeAlD
Caffeine—Impaired healing—Methotrexate—muscle cancer	0.000159	0.0364	CcSEcCtD
Caffeine—Sepsis—Dactinomycin—muscle cancer	0.000138	0.0315	CcSEcCtD
Caffeine—Urine output increased—Vincristine—muscle cancer	0.000128	0.0293	CcSEcCtD
Caffeine—PIK3CA—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000119	0.000524	CbGpPWpGaD
Caffeine—PRKDC—Innate Immune System—MDM2—muscle cancer	0.000119	0.000523	CbGpPWpGaD
Caffeine—ADORA2A—GPCR ligand binding—CNR1—muscle cancer	0.000119	0.000522	CbGpPWpGaD
Caffeine—PIK3CD—GPCR downstream signaling—CNR1—muscle cancer	0.000118	0.00052	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—FOXO4—muscle cancer	0.000118	0.000518	CbGpPWpGaD
Caffeine—CYP2C8—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000117	0.000516	CbGpPWpGaD
Caffeine—ATM—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	0.000117	0.000516	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by NGF—KIT—muscle cancer	0.000116	0.000511	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by NGF—MDM2—muscle cancer	0.000116	0.000511	CbGpPWpGaD
Caffeine—PRKDC—Immune System—FOXO1—muscle cancer	0.000115	0.000507	CbGpPWpGaD
Caffeine—Deafness—Vincristine—muscle cancer	0.000115	0.0263	CcSEcCtD
Caffeine—PIK3CA—DNA Damage Response (only ATM dependent)—TP53—muscle cancer	0.000114	0.0005	CbGpPWpGaD
Caffeine—PIK3CD—Disease—ENO2—muscle cancer	0.000113	0.000498	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—FOXO4—muscle cancer	0.000113	0.000498	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000112	0.000493	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—PTCH1—muscle cancer	0.000111	0.000488	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—FOXO1—muscle cancer	0.000111	0.000486	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—PTCH1—muscle cancer	0.00011	0.000483	CbGpPWpGaD
Caffeine—PIK3CB—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000109	0.000477	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KIDINS220—muscle cancer	0.000108	0.000476	CbGpPWpGaD
Caffeine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	0.000108	0.000474	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—CNR1—muscle cancer	0.000107	0.000472	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—FOXO1—muscle cancer	0.000106	0.000467	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—IGF2—muscle cancer	0.000105	0.000462	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—MED12—muscle cancer	0.000104	0.000457	CbGpPWpGaD
Caffeine—PIK3CB—GPCR downstream signaling—CNR1—muscle cancer	0.000103	0.000453	CbGpPWpGaD
Caffeine—PIK3CD—Disease—HMGA1—muscle cancer	0.000103	0.000452	CbGpPWpGaD
Caffeine—ADORA2B—GPCR downstream signaling—CNR1—muscle cancer	0.000102	0.000449	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CD34—muscle cancer	0.000101	0.000444	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—FOXO4—muscle cancer	0.0001	0.00044	CbGpPWpGaD
Caffeine—Sepsis—Etoposide—muscle cancer	9.96e-05	0.0228	CcSEcCtD
Caffeine—PIK3CB—Disease—ENO2—muscle cancer	9.87e-05	0.000434	CbGpPWpGaD
Caffeine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	9.84e-05	0.000432	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—KIT—muscle cancer	9.66e-05	0.000425	CbGpPWpGaD
Caffeine—PIK3CA—Focal Adhesion—VEGFA—muscle cancer	9.65e-05	0.000424	CbGpPWpGaD
Caffeine—PIK3CA—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	9.61e-05	0.000423	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by NGF—KIT—muscle cancer	9.61e-05	0.000422	CbGpPWpGaD
Caffeine—CYP2C9—Arachidonic acid metabolism—PTGS2—muscle cancer	9.56e-05	0.00042	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—ENO2—muscle cancer	9.49e-05	0.000417	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—CNR1—muscle cancer	9.37e-05	0.000412	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	9.36e-05	0.000412	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—PTCH1—muscle cancer	9.35e-05	0.000411	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—CNR1—muscle cancer	9.28e-05	0.000408	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—KIT—muscle cancer	9.28e-05	0.000408	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—PTCH1—muscle cancer	9.24e-05	0.000406	CbGpPWpGaD
Caffeine—PIK3CD—Disease—FOXO4—muscle cancer	9.24e-05	0.000406	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by NGF—MDM2—muscle cancer	9.17e-05	0.000403	CbGpPWpGaD
Caffeine—ATM—Cell Cycle—CDKN2A—muscle cancer	9.13e-05	0.000401	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—MED12—muscle cancer	9.07e-05	0.000399	CbGpPWpGaD
Caffeine—ATM—Cellular responses to stress—TP53—muscle cancer	9.06e-05	0.000398	CbGpPWpGaD
Caffeine—CYP1A2—Tryptophan metabolism—MDM2—muscle cancer	9.06e-05	0.000398	CbGpPWpGaD
Caffeine—PIK3CB—Disease—HMGA1—muscle cancer	8.97e-05	0.000394	CbGpPWpGaD
Caffeine—ATM—Cell Cycle—MDM2—muscle cancer	8.86e-05	0.000389	CbGpPWpGaD
Caffeine—PRKDC—Immune System—KIT—muscle cancer	8.79e-05	0.000386	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—PTCH1—muscle cancer	8.74e-05	0.000384	CbGpPWpGaD
Caffeine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	8.73e-05	0.000384	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—FOXO4—muscle cancer	8.72e-05	0.000383	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—FOXO1—muscle cancer	8.71e-05	0.000383	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—CNR1—muscle cancer	8.69e-05	0.000382	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—CNR1—muscle cancer	8.59e-05	0.000377	CbGpPWpGaD
Caffeine—Hypercalcaemia—Doxorubicin—muscle cancer	8.57e-05	0.0196	CcSEcCtD
Caffeine—PIK3CA—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	8.55e-05	0.000376	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—KIT—muscle cancer	8.42e-05	0.00037	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—FOXO1—muscle cancer	8.37e-05	0.000368	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—ENO2—muscle cancer	8.27e-05	0.000363	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	8.2e-05	0.00036	CbGpPWpGaD
Caffeine—CYP1A2—Arachidonic acid metabolism—PTGS2—muscle cancer	8.17e-05	0.000359	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—CNR1—muscle cancer	8.13e-05	0.000357	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—KIT—muscle cancer	8.09e-05	0.000355	CbGpPWpGaD
Caffeine—PIK3CB—Disease—FOXO4—muscle cancer	8.05e-05	0.000354	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—CNR1—muscle cancer	7.89e-05	0.000347	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—CNR1—muscle cancer	7.8e-05	0.000343	CbGpPWpGaD
Caffeine—PIK3CA—Disease—ENO2—muscle cancer	7.78e-05	0.000342	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—MDM2—muscle cancer	7.61e-05	0.000334	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by NGF—MDM2—muscle cancer	7.57e-05	0.000333	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—PTCH1—muscle cancer	7.52e-05	0.000331	CbGpPWpGaD
Caffeine—ADORA1—Circadian rythm related genes—TP53—muscle cancer	7.46e-05	0.000328	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	7.42e-05	0.000326	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—FOXO1—muscle cancer	7.39e-05	0.000325	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—CNR1—muscle cancer	7.38e-05	0.000324	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—FH—muscle cancer	7.38e-05	0.000324	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—MDM2—muscle cancer	7.31e-05	0.000321	CbGpPWpGaD
Caffeine—PIK3CA—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	7.26e-05	0.000319	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—PTCH1—muscle cancer	7.22e-05	0.000317	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—MED12—muscle cancer	7.15e-05	0.000314	CbGpPWpGaD
Caffeine—PIK3CA—Disease—HMGA1—muscle cancer	7.07e-05	0.000311	CbGpPWpGaD
Caffeine—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	6.99e-05	0.000307	CbGpPWpGaD
Caffeine—PRKDC—Immune System—MDM2—muscle cancer	6.93e-05	0.000304	CbGpPWpGaD
Caffeine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	6.88e-05	0.000302	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—FOXO4—muscle cancer	6.87e-05	0.000302	CbGpPWpGaD
Caffeine—PIK3CD—Disease—FOXO1—muscle cancer	6.82e-05	0.0003	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—CNR1—muscle cancer	6.71e-05	0.000295	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—FH—muscle cancer	6.66e-05	0.000292	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—KIT—muscle cancer	6.64e-05	0.000292	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—MDM2—muscle cancer	6.63e-05	0.000292	CbGpPWpGaD
Caffeine—Cardiac disorder—Vincristine—muscle cancer	6.6e-05	0.0151	CcSEcCtD
Caffeine—PIK3CB—Signaling Pathways—PTCH1—muscle cancer	6.56e-05	0.000288	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—ENO2—muscle cancer	6.52e-05	0.000286	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—PTCH1—muscle cancer	6.5e-05	0.000285	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	6.47e-05	0.000284	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—FOXO4—muscle cancer	6.47e-05	0.000284	CbGpPWpGaD
Caffeine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	6.46e-05	0.000284	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—FOXO1—muscle cancer	6.44e-05	0.000283	CbGpPWpGaD
Caffeine—PIK3CD—Hemostasis—VEGFA—muscle cancer	6.42e-05	0.000282	CbGpPWpGaD
Caffeine—Infestation—Etoposide—muscle cancer	6.42e-05	0.0147	CcSEcCtD
Caffeine—Infestation NOS—Etoposide—muscle cancer	6.42e-05	0.0147	CcSEcCtD
Caffeine—PIK3CA—Adaptive Immune System—KIT—muscle cancer	6.37e-05	0.00028	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—MDM2—muscle cancer	6.37e-05	0.00028	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CNR1—muscle cancer	6.35e-05	0.000279	CbGpPWpGaD
Caffeine—PIK3CA—Disease—FOXO4—muscle cancer	6.34e-05	0.000279	CbGpPWpGaD
Caffeine—Renal failure—Etoposide—muscle cancer	6.31e-05	0.0145	CcSEcCtD
Caffeine—Creatinine increased—Doxorubicin—muscle cancer	6.25e-05	0.0143	CcSEcCtD
Caffeine—Urine output increased—Methotrexate—muscle cancer	6.21e-05	0.0142	CcSEcCtD
Caffeine—Pulmonary oedema—Methotrexate—muscle cancer	6.12e-05	0.014	CcSEcCtD
Caffeine—ADORA2A—Signaling by GPCR—CNR1—muscle cancer	6.09e-05	0.000268	CbGpPWpGaD
Caffeine—Sepsis—Methotrexate—muscle cancer	5.96e-05	0.0137	CcSEcCtD
Caffeine—PIK3CB—Disease—FOXO1—muscle cancer	5.94e-05	0.000261	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	5.77e-05	0.000253	CbGpPWpGaD
Caffeine—ADORA2A—Circadian rythm related genes—TP53—muscle cancer	5.76e-05	0.000253	CbGpPWpGaD
Caffeine—Agitation—Vincristine—muscle cancer	5.69e-05	0.013	CcSEcCtD
Caffeine—PIK3CB—Signaling Pathways—FOXO4—muscle cancer	5.64e-05	0.000248	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—KIT—muscle cancer	5.63e-05	0.000247	CbGpPWpGaD
Caffeine—Infection—Dactinomycin—muscle cancer	5.62e-05	0.0129	CcSEcCtD
Caffeine—PIK3CB—Hemostasis—VEGFA—muscle cancer	5.6e-05	0.000246	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—VEGFA—muscle cancer	5.59e-05	0.000246	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—FOXO4—muscle cancer	5.59e-05	0.000245	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CNR1—muscle cancer	5.53e-05	0.000243	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—PTCH1—muscle cancer	5.52e-05	0.000243	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CNR1—muscle cancer	5.48e-05	0.000241	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PTCH1—muscle cancer	5.46e-05	0.00024	CbGpPWpGaD
Caffeine—Convulsion—Vincristine—muscle cancer	5.36e-05	0.0123	CcSEcCtD
Caffeine—Cardiac disorder—Etoposide—muscle cancer	5.35e-05	0.0123	CcSEcCtD
Caffeine—Hypertension—Vincristine—muscle cancer	5.35e-05	0.0123	CcSEcCtD
Caffeine—Pulmonary oedema—Doxorubicin—muscle cancer	5.3e-05	0.0121	CcSEcCtD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—MED12—muscle cancer	5.29e-05	0.000232	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—MDM2—muscle cancer	5.23e-05	0.00023	CbGpPWpGaD
Caffeine—Immune system disorder—Etoposide—muscle cancer	5.2e-05	0.0119	CcSEcCtD
Caffeine—PIK3CD—Disease—KIT—muscle cancer	5.2e-05	0.000228	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—IGF2—muscle cancer	5.19e-05	0.000228	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—PTCH1—muscle cancer	5.17e-05	0.000227	CbGpPWpGaD
Caffeine—Sepsis—Doxorubicin—muscle cancer	5.16e-05	0.0118	CcSEcCtD
Caffeine—PIK3CA—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	5.1e-05	0.000224	CbGpPWpGaD
Caffeine—ATM—Cell Cycle—TP53—muscle cancer	5.08e-05	0.000223	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—FOXO1—muscle cancer	5.07e-05	0.000223	CbGpPWpGaD
Caffeine—Infection—Vincristine—muscle cancer	5.02e-05	0.0115	CcSEcCtD
Caffeine—PIK3CA—Adaptive Immune System—MDM2—muscle cancer	5.02e-05	0.000221	CbGpPWpGaD
Caffeine—Nervous system disorder—Vincristine—muscle cancer	4.96e-05	0.0114	CcSEcCtD
Caffeine—PIK3CB—Immune System—KIT—muscle cancer	4.91e-05	0.000216	CbGpPWpGaD
Caffeine—PIK3CD—Hemostasis—TP53—muscle cancer	4.85e-05	0.000213	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—FH—muscle cancer	4.82e-05	0.000212	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—FH—muscle cancer	4.81e-05	0.000211	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—FOXO1—muscle cancer	4.78e-05	0.00021	CbGpPWpGaD
Caffeine—Irritability—Methotrexate—muscle cancer	4.76e-05	0.0109	CcSEcCtD
Caffeine—ADORA1—Signaling Pathways—FOXO4—muscle cancer	4.75e-05	0.000209	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—FOXO4—muscle cancer	4.69e-05	0.000206	CbGpPWpGaD
Caffeine—PIK3CA—Disease—FOXO1—muscle cancer	4.68e-05	0.000206	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CNR1—muscle cancer	4.66e-05	0.000205	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CNR1—muscle cancer	4.61e-05	0.000202	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—FH—muscle cancer	4.55e-05	0.0002	CbGpPWpGaD
Caffeine—PIK3CB—Disease—KIT—muscle cancer	4.53e-05	0.000199	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—IGF2—muscle cancer	4.52e-05	0.000199	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IGF2—muscle cancer	4.48e-05	0.000197	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—FOXO4—muscle cancer	4.44e-05	0.000195	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—MDM2—muscle cancer	4.43e-05	0.000195	CbGpPWpGaD
Caffeine—Hypoglycaemia—Doxorubicin—muscle cancer	4.43e-05	0.0101	CcSEcCtD
Caffeine—PIK3CA—Hemostasis—VEGFA—muscle cancer	4.41e-05	0.000194	CbGpPWpGaD
Caffeine—Gastrointestinal disorder—Vincristine—muscle cancer	4.36e-05	0.01	CcSEcCtD
Caffeine—PIK3CA—Signaling Pathways—CNR1—muscle cancer	4.36e-05	0.000192	CbGpPWpGaD
Caffeine—Convulsion—Etoposide—muscle cancer	4.35e-05	0.00996	CcSEcCtD
Caffeine—Hypertension—Etoposide—muscle cancer	4.33e-05	0.00992	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	4.32e-05	0.0099	CcSEcCtD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	4.3e-05	0.000189	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PTCH1—muscle cancer	4.26e-05	0.000187	CbGpPWpGaD
Caffeine—PIK3CB—Hemostasis—TP53—muscle cancer	4.23e-05	0.000186	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—MED12—muscle cancer	4.17e-05	0.000183	CbGpPWpGaD
Caffeine—Hypersensitivity—Dactinomycin—muscle cancer	4.17e-05	0.00955	CcSEcCtD
Caffeine—CYP2C8—Metabolism—FH—muscle cancer	4.17e-05	0.000183	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—FOXO1—muscle cancer	4.16e-05	0.000183	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—FOXO1—muscle cancer	4.12e-05	0.000181	CbGpPWpGaD
Caffeine—PIK3CD—Disease—MDM2—muscle cancer	4.09e-05	0.00018	CbGpPWpGaD
Caffeine—Infection—Etoposide—muscle cancer	4.07e-05	0.00932	CcSEcCtD
Caffeine—Blood creatinine increased—Doxorubicin—muscle cancer	4.05e-05	0.00927	CcSEcCtD
Caffeine—Tachycardia—Etoposide—muscle cancer	4e-05	0.00916	CcSEcCtD
Caffeine—Skin disorder—Etoposide—muscle cancer	3.98e-05	0.00911	CcSEcCtD
Caffeine—Dry skin—Doxorubicin—muscle cancer	3.96e-05	0.00907	CcSEcCtD
Caffeine—PIK3CD—Disease—PTGS2—muscle cancer	3.95e-05	0.000173	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—KIT—muscle cancer	3.87e-05	0.00017	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—MDM2—muscle cancer	3.86e-05	0.00017	CbGpPWpGaD
Caffeine—Infestation—Methotrexate—muscle cancer	3.84e-05	0.00881	CcSEcCtD
Caffeine—Infestation NOS—Methotrexate—muscle cancer	3.84e-05	0.00881	CcSEcCtD
Caffeine—Gastritis—Doxorubicin—muscle cancer	3.82e-05	0.00876	CcSEcCtD
Caffeine—ADORA1—Signaling Pathways—IGF2—muscle cancer	3.81e-05	0.000167	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—ENO2—muscle cancer	3.8e-05	0.000167	CbGpPWpGaD
Caffeine—Renal failure—Methotrexate—muscle cancer	3.78e-05	0.00866	CcSEcCtD
Caffeine—PDE4B—Signaling Pathways—IGF2—muscle cancer	3.77e-05	0.000166	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—MED12—muscle cancer	3.76e-05	0.000165	CbGpPWpGaD
Caffeine—Hypersensitivity—Vincristine—muscle cancer	3.72e-05	0.00853	CcSEcCtD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.68e-05	0.000162	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—FOXO4—muscle cancer	3.67e-05	0.000161	CbGpPWpGaD
Caffeine—Dyspnoea—Etoposide—muscle cancer	3.65e-05	0.00836	CcSEcCtD
Caffeine—PIK3CD—Signaling Pathways—KIT—muscle cancer	3.64e-05	0.00016	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	3.63e-05	0.00016	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—FH—muscle cancer	3.63e-05	0.00016	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CNR1—muscle cancer	3.6e-05	0.000158	CbGpPWpGaD
Caffeine—PIK3CA—Disease—KIT—muscle cancer	3.57e-05	0.000157	CbGpPWpGaD
Caffeine—PIK3CB—Disease—MDM2—muscle cancer	3.57e-05	0.000157	CbGpPWpGaD
Caffeine—Rash—Dactinomycin—muscle cancer	3.57e-05	0.00817	CcSEcCtD
Caffeine—PIK3CA—Signaling Pathways—IGF2—muscle cancer	3.56e-05	0.000157	CbGpPWpGaD
Caffeine—Gastrointestinal disorder—Etoposide—muscle cancer	3.53e-05	0.0081	CcSEcCtD
Caffeine—ADORA1—Signaling Pathways—FOXO1—muscle cancer	3.51e-05	0.000154	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	3.5e-05	0.000154	CbGpPWpGaD
Caffeine—Haemoglobin—Methotrexate—muscle cancer	3.47e-05	0.00795	CcSEcCtD
Caffeine—PDE4B—Signaling Pathways—FOXO1—muscle cancer	3.47e-05	0.000152	CbGpPWpGaD
Caffeine—Haemorrhage—Methotrexate—muscle cancer	3.45e-05	0.00791	CcSEcCtD
Caffeine—PIK3CB—Disease—PTGS2—muscle cancer	3.44e-05	0.000151	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—ENO2—muscle cancer	3.43e-05	0.000151	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—FH—muscle cancer	3.42e-05	0.00015	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—FH—muscle cancer	3.39e-05	0.000149	CbGpPWpGaD
Caffeine—Hyperglycaemia—Doxorubicin—muscle cancer	3.37e-05	0.00772	CcSEcCtD
Caffeine—PIK3CA—Hemostasis—TP53—muscle cancer	3.33e-05	0.000146	CbGpPWpGaD
Caffeine—Infestation—Doxorubicin—muscle cancer	3.33e-05	0.00763	CcSEcCtD
Caffeine—Infestation NOS—Doxorubicin—muscle cancer	3.33e-05	0.00763	CcSEcCtD
Caffeine—PIK3CD—Metabolism—PTGS2—muscle cancer	3.3e-05	0.000145	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—FOXO1—muscle cancer	3.28e-05	0.000144	CbGpPWpGaD
Caffeine—Renal failure—Doxorubicin—muscle cancer	3.27e-05	0.0075	CcSEcCtD
Caffeine—Cardiac disorder—Methotrexate—muscle cancer	3.2e-05	0.00734	CcSEcCtD
Caffeine—Rash—Vincristine—muscle cancer	3.19e-05	0.0073	CcSEcCtD
Caffeine—Dermatitis—Vincristine—muscle cancer	3.18e-05	0.0073	CcSEcCtD
Caffeine—PIK3CB—Signaling Pathways—KIT—muscle cancer	3.17e-05	0.000139	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—KIT—muscle cancer	3.14e-05	0.000138	CbGpPWpGaD
Caffeine—Immune system disorder—Methotrexate—muscle cancer	3.12e-05	0.00714	CcSEcCtD
Caffeine—PIK3CA—Immune System—MDM2—muscle cancer	3.04e-05	0.000134	CbGpPWpGaD
Caffeine—Hypersensitivity—Etoposide—muscle cancer	3.02e-05	0.00691	CcSEcCtD
Caffeine—Malnutrition—Methotrexate—muscle cancer	3e-05	0.00689	CcSEcCtD
Caffeine—Haemoglobin—Doxorubicin—muscle cancer	3e-05	0.00688	CcSEcCtD
Caffeine—Haemorrhage—Doxorubicin—muscle cancer	2.99e-05	0.00685	CcSEcCtD
Caffeine—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.97e-05	0.000131	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IGF2—muscle cancer	2.94e-05	0.000129	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—FH—muscle cancer	2.9e-05	0.000127	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—PTGS2—muscle cancer	2.88e-05	0.000127	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—MDM2—muscle cancer	2.87e-05	0.000126	CbGpPWpGaD
Caffeine—PIK3CA—Disease—MDM2—muscle cancer	2.81e-05	0.000124	CbGpPWpGaD
Caffeine—Cardiac disorder—Doxorubicin—muscle cancer	2.77e-05	0.00636	CcSEcCtD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	2.76e-05	0.000121	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—MED12—muscle cancer	2.72e-05	0.00012	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—MED12—muscle cancer	2.72e-05	0.000119	CbGpPWpGaD
Caffeine—PIK3CA—Disease—PTGS2—muscle cancer	2.71e-05	0.000119	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—FOXO1—muscle cancer	2.71e-05	0.000119	CbGpPWpGaD
Caffeine—Immune system disorder—Doxorubicin—muscle cancer	2.7e-05	0.00619	CcSEcCtD
Caffeine—ADORA1—Signaling Pathways—KIT—muscle cancer	2.67e-05	0.000117	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—KIT—muscle cancer	2.64e-05	0.000116	CbGpPWpGaD
Caffeine—Convulsion—Methotrexate—muscle cancer	2.6e-05	0.00597	CcSEcCtD
Caffeine—Malnutrition—Doxorubicin—muscle cancer	2.6e-05	0.00596	CcSEcCtD
Caffeine—Rash—Etoposide—muscle cancer	2.58e-05	0.00592	CcSEcCtD
Caffeine—Dermatitis—Etoposide—muscle cancer	2.58e-05	0.00591	CcSEcCtD
Caffeine—CYP1A1—Metabolism—MED12—muscle cancer	2.57e-05	0.000113	CbGpPWpGaD
Caffeine—Nervousness—Doxorubicin—muscle cancer	2.53e-05	0.00579	CcSEcCtD
Caffeine—PIK3CA—Signaling Pathways—KIT—muscle cancer	2.5e-05	0.00011	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—MDM2—muscle cancer	2.5e-05	0.00011	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ENO2—muscle cancer	2.48e-05	0.000109	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ENO2—muscle cancer	2.48e-05	0.000109	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—MDM2—muscle cancer	2.48e-05	0.000109	CbGpPWpGaD
Caffeine—Infection—Methotrexate—muscle cancer	2.44e-05	0.00558	CcSEcCtD
Caffeine—Nervous system disorder—Methotrexate—muscle cancer	2.4e-05	0.00551	CcSEcCtD
Caffeine—Agitation—Doxorubicin—muscle cancer	2.39e-05	0.00548	CcSEcCtD
Caffeine—Skin disorder—Methotrexate—muscle cancer	2.38e-05	0.00546	CcSEcCtD
Caffeine—CYP2C8—Metabolism—MED12—muscle cancer	2.35e-05	0.000103	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ENO2—muscle cancer	2.34e-05	0.000103	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—PTGS2—muscle cancer	2.27e-05	9.97e-05	CbGpPWpGaD
Caffeine—Convulsion—Doxorubicin—muscle cancer	2.25e-05	0.00517	CcSEcCtD
Caffeine—Hypertension—Doxorubicin—muscle cancer	2.25e-05	0.00515	CcSEcCtD
Caffeine—CYP3A4—Metabolism—FH—muscle cancer	2.24e-05	9.83e-05	CbGpPWpGaD
Caffeine—Dyspnoea—Methotrexate—muscle cancer	2.19e-05	0.00501	CcSEcCtD
Caffeine—PIK3CD—Signaling Pathways—VEGFA—muscle cancer	2.18e-05	9.56e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ENO2—muscle cancer	2.15e-05	9.43e-05	CbGpPWpGaD
Caffeine—Gastrointestinal disorder—Methotrexate—muscle cancer	2.12e-05	0.00485	CcSEcCtD
Caffeine—Infection—Doxorubicin—muscle cancer	2.11e-05	0.00483	CcSEcCtD
Caffeine—ADORA1—Signaling Pathways—MDM2—muscle cancer	2.1e-05	9.25e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	2.08e-05	9.16e-05	CbGpPWpGaD
Caffeine—Nervous system disorder—Doxorubicin—muscle cancer	2.08e-05	0.00477	CcSEcCtD
Caffeine—PDE4B—Signaling Pathways—MDM2—muscle cancer	2.08e-05	9.14e-05	CbGpPWpGaD
Caffeine—Tachycardia—Doxorubicin—muscle cancer	2.07e-05	0.00475	CcSEcCtD
Caffeine—ADORA2A—Signaling Pathways—KIT—muscle cancer	2.06e-05	9.07e-05	CbGpPWpGaD
Caffeine—Skin disorder—Doxorubicin—muscle cancer	2.06e-05	0.00473	CcSEcCtD
Caffeine—ABCB1—Metabolism—MED12—muscle cancer	2.05e-05	9.01e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MDM2—muscle cancer	1.97e-05	8.65e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—MED12—muscle cancer	1.93e-05	8.5e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—MED12—muscle cancer	1.92e-05	8.42e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—VEGFA—muscle cancer	1.9e-05	8.34e-05	CbGpPWpGaD
Caffeine—Dyspnoea—Doxorubicin—muscle cancer	1.89e-05	0.00434	CcSEcCtD
Caffeine—ADORA2B—Signaling Pathways—VEGFA—muscle cancer	1.88e-05	8.26e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ENO2—muscle cancer	1.87e-05	8.22e-05	CbGpPWpGaD
Caffeine—Gastrointestinal disorder—Doxorubicin—muscle cancer	1.83e-05	0.0042	CcSEcCtD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.83e-05	8.05e-05	CbGpPWpGaD
Caffeine—Hypersensitivity—Methotrexate—muscle cancer	1.81e-05	0.00414	CcSEcCtD
Caffeine—CYP2D6—Metabolism—ENO2—muscle cancer	1.76e-05	7.74e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ENO2—muscle cancer	1.75e-05	7.68e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.68e-05	7.38e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TP53—muscle cancer	1.64e-05	7.23e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—MED12—muscle cancer	1.64e-05	7.2e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MDM2—muscle cancer	1.63e-05	7.14e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—VEGFA—muscle cancer	1.6e-05	7.02e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—VEGFA—muscle cancer	1.58e-05	6.94e-05	CbGpPWpGaD
Caffeine—Hypersensitivity—Doxorubicin—muscle cancer	1.56e-05	0.00358	CcSEcCtD
Caffeine—Rash—Methotrexate—muscle cancer	1.55e-05	0.00354	CcSEcCtD
Caffeine—Dermatitis—Methotrexate—muscle cancer	1.54e-05	0.00354	CcSEcCtD
Caffeine—PIK3CA—Signaling Pathways—VEGFA—muscle cancer	1.49e-05	6.57e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ENO2—muscle cancer	1.49e-05	6.56e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TP53—muscle cancer	1.43e-05	6.3e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TP53—muscle cancer	1.42e-05	6.24e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.37e-05	6e-05	CbGpPWpGaD
Caffeine—Rash—Doxorubicin—muscle cancer	1.34e-05	0.00307	CcSEcCtD
Caffeine—Dermatitis—Doxorubicin—muscle cancer	1.34e-05	0.00307	CcSEcCtD
Caffeine—CYP1B1—Metabolism—PTGS2—muscle cancer	1.32e-05	5.82e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—MED12—muscle cancer	1.26e-05	5.55e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—VEGFA—muscle cancer	1.23e-05	5.42e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TP53—muscle cancer	1.21e-05	5.31e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTGS2—muscle cancer	1.19e-05	5.25e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TP53—muscle cancer	1.19e-05	5.24e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.17e-05	5.13e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ENO2—muscle cancer	1.15e-05	5.06e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TP53—muscle cancer	1.13e-05	4.96e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TP53—muscle cancer	9.32e-06	4.1e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTGS2—muscle cancer	8.65e-06	3.8e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTGS2—muscle cancer	8.63e-06	3.79e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTGS2—muscle cancer	8.16e-06	3.58e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTGS2—muscle cancer	7.48e-06	3.29e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTGS2—muscle cancer	6.51e-06	2.86e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTGS2—muscle cancer	6.14e-06	2.7e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTGS2—muscle cancer	6.08e-06	2.67e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTGS2—muscle cancer	5.2e-06	2.29e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS2—muscle cancer	4.01e-06	1.76e-05	CbGpPWpGaD
